Sources | Names Used |
---|---|
CCLE, FIMM | Vandetanib |
CTRPv2 | vandetanib |
PharmacoGx | Vandetanib |
Database | Identifier |
---|---|
Smiles: | CN1CCC(CC1)COC2=C(C=C3C(=C2)N=CN=C3NC4=C(C=C(C=C4)Br)F)OC |
Inchikey: | UHTHHESEBZOYNR-UHFFFAOYSA-N |
Pubchem: | 3081361 |
Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | MRPL23 | CCLE | pan-cancer | AAC | -0.16 | 0.001 |
mRNA | ARAF | CCLE | pan-cancer | AAC | -0.15 | 0.001 |
mRNA | NFYA | FIMM | pan-cancer | AAC | 0.54 | 0.001 |
mRNA | MLLT10 | FIMM | pan-cancer | AAC | 0.57 | 0.001 |
mRNA | CTB-50L17.10 | CTRPv2 | pan-cancer | AAC | -0.12 | 0.001 |
mRNA | ESRP2 | CCLE | pan-cancer | AAC | 0.21 | 0.001 |
mRNA | SCEL | CCLE | pan-cancer | AAC | 0.17 | 0.001 |
mRNA | RXRA | CCLE | pan-cancer | AAC | 0.18 | 0.001 |
mRNA | C1QTNF6 | CCLE | pan-cancer | AAC | 0.16 | 0.001 |
mRNA | MAP1LC3B | CCLE | pan-cancer | AAC | -0.15 | 0.001 |